The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Epidemiology of headache in Europe
Open accessAbstract
The present review of epidemiologic studies on migraine and headache in Europe is part of a larger initiative by the European Brain Council to estimate the costs incurred because of brain disorders. Summarizing the data on 1‐year prevalence, the proportion of adults in Europe reporting headache was 51%, migraine 14%, and ‘chronic headache’ (i.e. ≥15 days/month or ‘daily’) 4%. Generally, migraine, and to a lesser degree headache, are most prevalent during the most productive years of adulthood, from age 20 to 50 years. Several European studies document the negative influence of headache disorders on the quality of life, and health‐economic studies indicate that 15% of adults were absent from work during the last year because of headache. Very few studies have been performed in Eastern Europe, and there are also surprisingly little data on tension‐type headache from any country. Although the methodology and the quality of the published studies vary considerably, making direct comparisons between different countries difficult, the present review clearly demonstrates that headache disorders are extremely prevalent and have a vast impact on public health. The data collected should be used as arguments to increase resources to headache research and care for headache patients all over the continent.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As far as Europe is concerned, good data exist on migraine prevalence derived from a number of western countries [17,18].”
From The impact of headache in Europe: principal results of the Eurolight project (2014) · cites this paper as [18]
Citations
Cites
Sorge, F., Simone, R. D., Marano, E., Nolano, M., Orefice, G., & Carrieri, P. B. (1988) · Cephalalgia · doi:10.1046/j.1468-2982.1988.0801001.x · Cited by 3,464
Goadsby, P. J. (2004) · Cephalalgia · doi:10.1111/j.1468-2982.2004.00711.x · Cited by 2,381
The International Classification of Headache Disorders
Olesen, J. (2008) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2008.01121.x · Cited by 2,321
Stewart, A. L. (1989) · JAMA · doi:10.1001/jama.262.7.907 · Cited by 2,095
Epidemiology of headache in a general population—A prevalence study
Rasmussen, B. K., Jensen, R., Schroll, M., & Olesen, J. (1991) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(91)90147-2 · Cited by 1,457
Prevalence of headache and migraine in schoolchildren
Abu-Arefeh, I., & Russell, G. (1994) · BMJ · doi:10.1136/bmj.309.6957.765 · Cited by 770
The international classification of headache disorders
(2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.05.044 · Cited by 730
Epidemiology of Chronic Daily Headache in the General Population
Castillo, J., Muñoz, P., Guitera, V., & Pascual, J. (1999) · Headache The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.1999.3903190.x · Cited by 711
Self-citationThe prevalence and characteristics of migraine in a population-based cohort
Launer, L. J., Terwindt, G. M., & Ferrari, M. D. (1999) · Neurology · doi:10.1212/wnl.53.3.537 · Cited by 587
Self-citationBILLE, B. S. V. (1962) · Acta Paediatrica · doi:10.1111/j.1651-2227.1962.tb06591.x · Cited by 562
Research works printed but not linked: 8
- Mathers CD, 2002, Global Burden of Disease 2000: version 2, methods and results
- International Headache Society, 1997, ICD‐10 Guide for Headaches, Cephalalgia, 17, 1
- 10.1046/j.1468-2982.2003.00546.x · DOI
- Scher AI, 1983, Epidemiology of Pain, 159
- Laínez MJA, 1994, Frontiers in Headache Research: Headache Classification and Epidemiology, 221
- Raieli V, 1995, Cephalalgia, 5
- Abu‐Arafeh IA, 1993, Epidemiology of headache and migraine in children, Developmental Medicine and Child Neurology, 35, 370
- Merikangas KR, 1994, Frontiers in Headache Research: Headache Classification and Epidemiology, 301
Cited by
Sorted by citations
Items 201–300 of 421
Maher, B. H., Kerr, M., Cox, H. C., MacMillan, J., Brimage, P. J., Esposito, T., Gianfrancesco, F., Haupt, L. M., Nyholt, D. R., Lea, R. A., et al. (2012) · Neurogenetics · doi:10.1007/s10048-011-0312-7 · Cited by 13
“The biased preponderance of migraine in women [2, 3], as well as studies that demonstrate that a high proportion of Electronic supplementary material The online version of this article (doi:10.”
BackgroundSurvival outcome and mortality rate in patients with migraine: a population-based cohort study
Harnod, T., Lin, C., & Kao, C. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0889-4 · Cited by 13
Corominas, R., Ribasés, M., Cuenca-León, E., Narberhaus, B., Serra, S. A., del Toro, M., Roig-Quilis, M., Fernández‐Fernández, J. M., Macaya, A., & Cormand, B. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.03.011 · Cited by 13
Deng, Z.-Q., Zheng, H., Zhao, L., Zhou, S., Li, Y., & Liang, F. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-75 · Cited by 13
“; licensee BioMed Central L Commons Attribution License (http://creativec reproduction in any medium, provided the or having higher rates than males [2,3].”
BackgroundCharacteristics of Headache and Relationship to Acute Mountain Sickness at 4559 Meters
Schneider, M., & Bärtsch, P. (2018) · High Altitude Medicine & Biology · doi:10.1089/ham.2018.0025 · Cited by 12
“This gender-based difference of prevalence of migraine is comparable with values reported in a meta-analysis of 7.5% in male and 16.6% in female subjects (Stovner et al., 2006).”
InfluentialPredicting treatment response using pharmacy register in migraine
Hansen, T. F., Chalmer, M. A., Haspang, T. M., Kogelman, L. J. A., & Olesen, J. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-0987-y · Cited by 12
Migraine in Patients With Eating Disorders: A Study Using a Sister‐Pair Comparison Design
Seidel, S., Karwautz, A. F. K., Wagner, G., Zormann, A., Eder, H., Huemer, J., Nattiashvili, S., Wöber, C., & Wöber‐Bingöl, Ç. (2011) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2010.01822.x · Cited by 12
Raggi, A., Leonardi, M., Giovannetti, A. M., Curone, M., Bussone, G., & D’Amico, D. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0535-2 · Cited by 12
“5% [6], the burden on economic and labour systems is considerable.”
BackgroundHarnod, T., Wang, Y.-C., & Kao, C. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.03.002 · Cited by 12
“The prevalence of migraines is well known to be higher from young adulthood tomiddle age, with a higher prevalence inwomen thanmen, and then to decrease among elderly persons [2–4].”
BackgroundThe Course of Migraine—A Diary Study in Unselected Patients
Lieba‐Samal, D., Bartl, S., Salhofer‐Polanyi, S., Prajsnar-Borak, A., Massl, R., Freydl, E., Fathinia, P., Wöber, C., & Wöber, C. (2009) · Cephalalgia · doi:10.1111/j.1468-2982.2008.01838.x · Cited by 12
Maier, J., Sebastian, I., Weisbrod, M., Freitag, C. M., Resch, F., & Bender, S. (2011) · Cephalalgia · doi:10.1177/0333102411408627 · Cited by 12
“78), univariate ANOVAs showed that for no TMS intensity was there a significant influence of age (100% RMT F(1,44)1⁄4 2.”
BackgroundYoung, W. B. (1997) · PubMed · Cited by 12
Primary headache types in adult epilepsy patients
Schiller, K., Rauchenzauner, M., Avidgor, T., Hannan, S., Lorenzen, C., Kaml, M., Walser, G., Unterberger, I., Filippi, V., Broessner, G., et al. (2023) · European journal of medical research · doi:10.1186/s40001-023-01023-8 · Cited by 11
Consensus recommendations on the role of nurses in headache care: A European e-Delphi study
Rasmussen, A. V., Jensen, R., Gantenbein, A. R., Sumelahti, M., Braschinsky, M., Lagrata, S., Tamela, K., Trouerbach‐Kraan, J. P., Matharu, M. S., Dalevi, V., et al. (2024) · Cephalalgia · doi:10.1177/03331024241252161 · Cited by 14
Behavioral therapy in migraine: Expanding the therapeutic arsenal
Mínguez‐Olaondo, A., Días, P. A., de Munáin, E. L., Grozeva, V., Laspra‐Solís, C., Martín‐Villalba, I., García‐Martín, V., Vila‐Pueyo, M., Barandiarán, M., Zabalza, R., et al. (2024) · European Journal of Neurology · doi:10.1111/ene.16414 · Cited by 11
Mohammadi, M., Ayoobi, F., Khalili, P., Soltani, N. S., Vecchia, C. L., & Vakilian, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-03377-7 · Cited by 11
Acute migraine in the Emergency Department: extending European principles of management
Martelletti, P., Farinelli, I., Steiner, T. J., & on behalf of the Working Group for Specialist Education, W. G. C. T. R. T. B. O. H. W. (. T. B. (2008) · Internal and Emergency Medicine · doi:10.1007/s11739-008-0188-1 · Cited by 11
Possible relationships between headache–allodynia and nocturnal sleep breathing
Lovati, C., Zardoni, M., D’Amico, D., Pecis, M., Giani, L., Raimondi, E., Bertora, P., Legnani, D., Bussone, G., & Mariani, C. B. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0558-8 · Cited by 11
Mongini, F., Evangelista, A., Rota, E., Ferrero, L., Ugolini, A., Milani, C., Ceccarelli, M., Joffrain, L., Ciccone, G., & Galassi, C. (2010) · The Journal of Headache and Pain · doi:10.1007/s10194-010-0231-2 · Cited by 11
“However, the weight of the evidence is still limited and the results of recent studies are conflicting and often limited by relatively short follow-up periods [1–9].”
ResultVision status and reading test results in Norwegian adolescents
Hagen, L. A., Gilson, S. J., & Baraas, R. C. (2020) · Scandinavian Journal of Optometry and Visual Science · doi:10.5384/sjovs.vol13i2p2-7 · Cited by 11
Jacobsena, B. A., Dyb, G. A., Hagen, K., Stovner, L. J., Holmen, T. L., & Zwart, J. (2011) · Scandinavian Journal of Pain · doi:10.1016/j.sjpain.2011.03.002 · Cited by 11
“Differences n classification, study methodology and population samples have een accepted as explanations of this variability [8].”
BackgroundSelf-citationSandrini, G., Perrotta, A., Tassorelli, C., & Nappi, G. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903410226 · Cited by 11
Prevalence and Incidence of Headache in Adolescent Finnish Twins
Virtanen, R., Aromaa, M. E., Koskenvuo, M., Sillanpää, M. L., Rose, R. J., Metsähonkala, L., Helenius, H. Y. M., Anttila, P., & Kaprio, J. A. (2009) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2009.01528.x · Cited by 10
“On the other hand, the 3-month and 1-year prevalence rates do not differ much in children and adolescents.(15) In the present study we tried to have comparable assessments of headache frequency at different follow-up points.”
BackgroundCharacteristics of the first 2000 patients registered in a specialist headache clinic
Pedraza, M. I., Mulero, P., Ruíz, M., de la Cruz, C., Herrero, S., & Guerrero, A. L. (2015) · Neurología (English Edition) · doi:10.1016/j.nrleng.2015.03.002 · Cited by 10
“Headache can have a significant impact on the patients’ quality of life, leading to high direct and indirect financial costs.(1,4) The second edition of the International Classification of Headache Disorders (ICHD-II)(5) helps doctors assign the appropriate diagnosis for each patient, which is essential for managing h…”
BackgroundAlmotriptan in the treatment of migraine
Sandrini, G. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s487 · Cited by 10
“The estimated mean prevalence of migraine in Europe is 16.6% in women and 7.5% in men (Stovner et al 2006); in the US, the corresponding fi gures are 18.2% and 6.5% (Lipton et al 2001).”
InfluentialRole of NSAIDs in acute treatment of headache
Martelletti, P., Farinelli, I., Coloprisco, G., & Patacchioli, F. R. (2007) · Drug Development Research · doi:10.1002/ddr.20191 · Cited by 10
“Of this population, 14% are affected by migraine and 4% by a chronic form of headache (chronic daily headache [CDH]) [Stovner et al., 2006].”
BackgroundEkosse, G.-I. (2008) · Journal of Applied Sciences · doi:10.3923/jas.2008.2344.2356 · Cited by 10
Liu, H., & Duan, S. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.02.008 · Cited by 9
The estrous cycle modulates voltage-gated ion channels in trigeminal ganglion neurons
Saleeon, W., Jansri, U., Srikiatkhachorn, A., & Bongsebandhu‐phubhakdi, S. (2015) · The Journal of Physiological Sciences · doi:10.1007/bf03405853 · Cited by 9
Marcos, V. M., Etessam, J. P., Bertolín, S. A., Larios, C., Garcia, M. G., & investiga, E. R. D. L. I. E. R. D. L. (2012) · Revista de Neurología · doi:10.33588/rn.5510.2012295 · Cited by 9
“Afecta principalmente a pacientes entre los 20 y 50 años de edad, con un neto predominio femenino [1].”
BackgroundHartberg, S., Clench‐Aas, J., Raanaas, R. K., & Lundqvist, C. (2015) · SpringerPlus · doi:10.1186/s40064-015-1599-x · Cited by 9
Towards the discrimination of primary and secondary headache: An intelligent systems approach
Keight, R., Al‐Jumeily, D., Hussain, A. J., Al-Jumeily, M., & Mallucci, C. L. (2017) · International Joint Conference on Neural Networks (IJCNN) · doi:10.1109/ijcnn.2017.7966197 · Cited by 9
Needle-Free Subcutaneous Sumatriptan
Frampton, J. E. (2011) · CNS Drugs · doi:10.2165/11208230-000000000-00000 · Cited by 8
León, I. M., Díaz, M. E. T., Carod-Artal, F. J., Martínez, M. L. P., Ruiz, L., Domínguez, E., Pedraza, M. I., Molina, V., Peral, Á. L. G., & Ladrón, F. U. (2013) · Revista de Neurología · doi:10.33588/rn.5712.2013342 · Cited by 8
Prevalence and burden of headache disorders in two neighboring provinces of China
Luo, N., Qi, W., Tong, W., Tan, F., Zhang, Q., He, J.-M., Zou, D., Cao, X., Xu, X., Bai, H., et al. (2014) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2014.01.023 · Cited by 8
“Previous studies have revealed that variation of the prevalence of primary headache among districts occurs due to environmental factors, genetic variation, cultural diversity, different methodology and varying diagnostic criteria [3,10].”
BackgroundZahid, M., Sthanadar, A. A., Kaleem, M., Latif, M., Sthanadar, I. A., Ali, P. A., Sthanadar, I. A., Khan, M. I., Imtiaz, N., & Shah, M. (2014) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2014.56061 · Cited by 8
“Previous studies have shown that the frequency of migraine is three times more in women than men [3].”
BackgroundPorta-Etessam, J., López‐Gil, A., Matías‐Guiu, J., & Fernández, C. (2010) · Neurología · doi:10.1016/s0213-4853(10)70004-9 · Cited by 8
Golovacheva, V. A., Pozhidaev, K. A., & Александровна, Г. А. (2018) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2018-3-141-149 · Cited by 9
Rizatriptan as an Over-the-Counter Triptan in the Treatment of Migraine Attacks
Göbel, C. H., Heinze, A., Cirkel, A., & Göbel, H. (2024) · Pain and Therapy · doi:10.1007/s40122-024-00625-2 · Cited by 7
“Headache disorders can vary greatly in severity [10, 12, 15, 25, 26, 30].”
BackgroundMigraine-Associated Vertigo: A Review of the Pathophysiology and Differential Diagnosis
Fasunla, A. J., Ibekwe, T., & Nwaorgu, O. G. B. (2011) · International Journal of Neuroscience · doi:10.3109/00207454.2011.631717 · Cited by 7
Onderwater, G. L. J., van Dongen, R. M., Zielman, R., Terwindt, G. M., & Ferrari, M. D. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804279-3.00016-2 · Cited by 8
“Studies from throughout the world consistently report lifetime migraine prevalence ranging from 17% to 33% in women and from 8% to 22% in men (Launer et al., 1999; Stovner et al., 2006; Buse et al., 2013).”
BackgroundSelf-citationReview of botulinum toxin type A for the prophylactic treatment of chronic daily headache
Evers, S. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s1665 · Cited by 7
“Since this total patient group shows a prevalence of up to 4% in population based epidemiological studies (Stovner et al 2006), it is warranted to further elucidate the clinical effi cacy of botulinum toxin in this subgroup.”
Guidotti, M., & Ravasio, R. (2009) · Clinical Drug Investigation · doi:10.2165/11315330-000000000-00000 · Cited by 7
FAN, L. Y., Lin, Q., YANG, N. Y., & CHEN, L. H. (2020) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.634 · Cited by 7
Why Do Migraines Often Decrease As We Age?
Freitag, F. G. (2013) · Current Pain and Headache Reports · doi:10.1007/s11916-013-0366-3 · Cited by 7
Migräne bei Kopfschmerzexperten und Neurologen
Brockmann, N., & Evers, S. (2007) · Der Schmerz · doi:10.1007/s00482-007-0610-z · Cited by 7
Investigating prophylactic botulinum toxin type A for chronic headache disorders
Evers, S. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.10.1161 · Cited by 7
“As this total patient group shows a prevalence of ≤ 4% in population-based epidemiological studies [36], it is warranted to further elucidate the clinical efficacy of botulinum toxin in this subgroup.”
BackgroundUygunoğlu, U., & Sıva, A. (2015) · Headache · doi:10.1007/978-3-319-19911-5_2 · Cited by 7
Safety of drugs used for the treatment of migraine during pregnancy: a narrative review
Spiteri, J. A., Camilleri, G., Piccinni, C. P., & Sultana, J. (2023) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2181157 · Cited by 6
Lin, P., Hseu, S., Fuh, J., Lirng, J., Chen, S., Chen, W., Wang, S., & Wang, Y.-F. (2024) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14816 · Cited by 6
“Like in migraine and some other headache disorders, 18,19 there is a female preponderance in SIH.”
IMPACT OF ACUTE MIGRAINE HEADACHE AMONGST UNIVERSITY STUDENTS IN NORTH - EASTERN NIGERIA
Sy, T., Mava, Y., Hj, B., & Ay, B. (2012) · International Research Journal of Pharmacy · Cited by 6
Pellesi, L., Bellei, E., Guérzoni, S., Cainazzo, M. M., Baraldi, C., Monari, E., & Pini, L. A. (2019) · BMC Neurology · doi:10.1186/s12883-019-1469-1 · Cited by 6
Estudio epidemiológico sobre cefaleas en población universitaria española
Cebrián, R. P., Fernández-Marcos, T., & Herrera, T. L. (2017) · Psychologia · doi:10.21500/19002386.2785 · Cited by 6
Kubaisi, K. A., Hasan, S., Hassan, N. A., & Elnour, A. A. (2022) · Pharmacy Practice · doi:10.18549/pharmpract.2022.4.2739 · Cited by 5
Nouri, M., Rahimnejad, M., Najafpour, G. D., & Moghadamnia, A. A. (2023) · Environmental Research · doi:10.1016/j.envres.2023.116801 · Cited by 5
Traini, E., Smith, R. B., Vermeulen, R. C. H., Kromhout, H., Schüz, J., Feychting, M., Auvinen, A. P., Poulsen, A. H., Deltour, I., Muller, D. C., et al. (2024) · Environmental Research · doi:10.1016/j.envres.2024.118290 · Cited by 5
Olofsson, I. A., Kristjansson, R. P., Callesen, I., Davidsson, O. B., Winsvold, B. S., Hjalgrim, H., Ostrowski, S. R., Erikstrup, C., Bruun, M. T., Pedersen, O. B., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06299-y · Cited by 5
“The DBDS dataset was approved by The Scienti fi c Ethical Committee of Central Denmark (1-10-72-95-13) and of Zealand Region (SJ-740).”
Gv, E.-L., & Oliva‐Pascual‐Vaca, Á. (2012) · Repository of Digital Objects for Teaching Research and Culture (University of Valencia) · Cited by 5
Does a History of Migraine Affect the Rate of Thrombolysis in Young Stroke Patients?
Øygarden, H., Kvistad, C. E., Thomassen, L., Waje‐Andreassen, U., & Næss, H. (2013) · Stroke Research and Treatment · doi:10.1155/2013/351064 · Cited by 5
“Migrainous attacks are common with almost 14% of young adults experiencing a migrainous attack in one year [3].”
BackgroundManagement of acute and chronic migraine
Coppola, G., & Schoenen, J. E. (2012) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e3283521dc3 · Cited by 5
“Chronic headache is a disabling health problem that affects 2–5% of the general population and causes considerable long-term morbidity and disability [28].”
BackgroundWrist-worn Wearable Sensors to Understand Insides of the Human Body
Siirtola, P., Peltonen, E., Koskimäki, H., Mönttinen, H., Röning, J., & Pirttikangas, S. (2019) · doi:10.1145/3325424.3329663 · Cited by 5
“Indeed, it is estimated that 15% of people in developed countries suffer from migraine and the yearly costs of these in Europe are 111 Billion Euros [17].”
BackgroundClinical use of copeptin in migraine patients admitted to the emergency department
YILMAZ, D. Y., Armağan, H. H., Karaman, K., Şirin, F. B., Bozkurt, M., Karaibrahimoğlu, A., Yalçın, İ. G., Beceren, N. G., & Tomruk, Ö. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.05.009 · Cited by 5
Bhat, K., Dengale, S. J., Muddukrishna, B., Reddy, M., Avadani, K., & Bhagawati, S. T. (2014) · Journal of Basic and Clinical Pharmacy · doi:10.4103/0976-0105.145766 · Cited by 5
“Physiologically, the migraine is a neurological condition, which is about three times more common to women than men.[1] Rizatriptan benzoate is known chemically as N, N-dimethyl-5-(1H-1,2,4-triazol-1ylmethyl)-1H-indole-3-ethanamine monobenzoate [Figure 1], binds to human 5-hydroxytryptamine 1B/1D receptor with high af…”
BackgroundEpidemiology of Migraine in Men and Women
Vetvik, K. G. (2019) · Headache · doi:10.1007/978-3-030-02988-3_1 · Cited by 5
Oral contraceptive use and its association with symptomatology in migraine patients
Peng, K., & May, A. (2019) · Cephalalgia Reports · doi:10.1177/2515816319856007 · Cited by 5
“An increased female prevalence starts after menarche, peaks around the age of 40, and gradually decreases after menopause.(2) In women with migraine during their reproductive years, 35–54% of them reported prominent menstruallyrelated worsening of headache.”
BackgroundHeadache in Behçet’s disease: case reports and literature review
Volpinari, S., Monaldini, C., Capone, J. G., Monaco, A. L., Corte, R. L., Trotta, F., & Govoni, M. (2011) · Reumatismo · doi:10.4081/reumatismo.2009.174 · Cited by 5
“riporta, in Italia, una prevalenza media di cefalea globale nella popolazione generale pari al 50% (15).”
Jayarathna, D. G. A. I., & Bandara, S. M. R. (2014) · Journal of Neurological Disorders · doi:10.4172/2329-6895.1000175 · Cited by 5
“Migraine is a common neurological disorder and affects about 15% of people in developed countries [1], which is co-morbid with many neurological illness such as stroke [2], epilepsy [3], motion sickness [4], vertigo [5], balance disorder [6] and benign intra cranial hypertension [7], Narcolepsy [8].”
BackgroundStraube, A., & Gaul, C. (2015) · Der Schmerz · doi:10.1007/s00482-015-0040-2 · Cited by 5
Zittoon, R. F., Ahmed, D. I., Iskander, N. M., & Madian, Y. T. (2021) · The Egyptian Journal of Otolaryngology · doi:10.1186/s43163-021-00077-x · Cited by 4
Moazami, T. N., & Sterud, T. (2024) · Indoor and Built Environment · doi:10.1177/1420326x241290514 · Cited by 4
Enhancing White-Box Machine Learning Processes by Incorporating Semantic Background Knowledge
Vandewiele, G. (2017) · Lecture notes in computer science · doi:10.1007/978-3-319-58451-5_21 · Cited by 4
“In Europe, it has a prevalence of more than 50% and according to the World Health Organization (WHO), severe headache attacks are one of the top 10 most disabling conditions [10].”
BackgroundAn Interesting Tour of New Research Results on Umami and Umami Compounds
Greisinger, S., Jovanovski, S., & Buchbauer, G. (2016) · Natural Product Communications · doi:10.1177/1934578x1601101040 · Cited by 4
“A migraine is three times more likely to occur in women than in men [44,45].”
BackgroundChronic headache in tabari cohort population: Prevalence and its related risk factors
Ahmadi, M., Nasehi, M. M., Kheradmand, M., & Moosazadeh, M. (2019) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2019.05.003 · Cited by 4
Mirmosayyeb, O., Shaygannejad, V., & Ghajarzadeh, M. (2020) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s260056 · Cited by 4
No Association Between Bipolar Disorder Risk Polymorphisms in ANK3 and CACNA1C and Common Migraine
Wöber‐Bingöl, Ç., Tropeano, M., Karwautz, A. F. K., Wagner, G., Campos‐de‐Sousa, S., Zesch, H. E., Kienbacher, C., Natriashvili, S., Kanbur, I., Ray, M., et al. (2011) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2011.01858.x · Cited by 5
“Migraine is a complex neurological disorder with a current global prevalence higher than 10%(1) and peaks in Europe (14%) and North America (12%).(2,3) It has a multifactorial basis, with family and twin studies revealing that both genetic and environmental factors are important in the pathogenesis of the disease.”
BackgroundIMPACT OF WEATHER CONDITIONS ON MIGRAINE HEADACHE IN NORTHEASTERN NIGERIA
Sy, T., Ho, K., Yw, N., Watila, M. M., Gu, S., Di, M., & Abdussalam, B. (2011) · Cited by 4
Prevalence of Headache in Cochlear Implant Patients
Kisser, U., Adderson-Kisser, C., Förster, M., Stelter, K., Nicoló, M. S., Schrötzlmair, F., Müller, J. M., & Hempel, J. M. (2016) · Otology & Neurotology · doi:10.1097/mao.0000000000001244 · Cited by 4
Epidemiology of Common Headache Disorders
Stovner, L. J., & Haimanot, R. T. (2011) · Springer eBooks · doi:10.1007/978-88-470-1700-9_2 · Cited by 4
Self-citationMigraine : données épidémiologiques, cliniques et thérapeutiques
Roos, C. (2019) · Biologie Aujourd hui · doi:10.1051/jbio/2019019 · Cited by 3
Rasmussen, A. V., Jensen, R., Karlsson, L. E., & Mose, L. S. (2023) · BMC Nursing · doi:10.1186/s12912-023-01211-1 · Cited by 3
“Migraine often affects everyday life causing social absence, decreased quality of life, lack of control, and reduced work- and functional capacity [2, 4, 5].”
BackgroundThe prevalence and impact of tension-type headache in school-aged children in Iran
Togha, M., Jafari, E., Salami, Z., Kamali, K., Godarzee, H. M., Godarzee, M. M., & Bavarnegin, S. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1259624 · Cited by 3
“It should be noted that epidemiological studies on headaches have utilized various definitions and classifications, which can pose challenges when comparing the data (7).”
BackgroundThe Global Burden of Headache in Published Studies
Stovner, L. J., & Steiner, T. J. (2019) · Headache · doi:10.1007/978-3-030-24728-7_8 · Cited by 3
Self-citationBiofeedback: An Effective Add-on Treatment for Migraine Headache Alongside Medication Therapy
Tehrani, M. R. H., Ghoreishi, A., Ghoreishi, A., Kalhor, K., & Khosravi, A. (2020) · Journal of Advances in Medical and Biomedical Research · doi:10.30699/jambs.29.132.14 · Cited by 3
“One of the most common headache types is the migraine headache (1).”
BackgroundPorta-Etessam, J., López‐Gil, A., Matías‐Guiu, J., & Fernández, C. (2010) · Neurología (English Edition) · doi:10.1016/s2173-5808(10)70032-8 · Cited by 3
Epidemiologie von Kopfschmerzen
Göbel, H. (2012) · Springer eBooks · doi:10.1007/978-3-642-20695-5_4 · Cited by 3
Eid, R., Hage, S. F., Antonios, I., Moussa, R., Khoury, M., Haddad, F. G., Kourié, H. R., Kesrouani, C., Ghorra, C. S., Abadjian, G., et al. (2020) · CNS Oncology · doi:10.2217/cns-2020-0001 · Cited by 3
Park, J.-H., Kong, G.-S., Song, J., Kim, S.-W., Wang, Y.-M., Kim, S.-Y., Kang, M.-H., Park, S., Eom, G.-H., Lee, H.-C., et al. (2021) · The Journal of Internal Korean Medicine · doi:10.22246/jikm.2021.42.5.893 · Cited by 3
“2) NDI 2020년 11월 23일 입원 당시의 NDI는 26점으로 ‘중증 장애(25-34)’에 해당하였고, 2020년 12월 2일 퇴원 당시의 NDI는 20점으로 ‘중등도 장애(15-24)’ 에 해당하였다.”
Pushpa Latha, E., & Bandhakavi, S. (2021) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2021.01043 · Cited by 3
Specific Psychosomatic Disorders
Brann, L. (2011) · Wiley eBooks · doi:10.1002/9781119950905.ch19 · Cited by 3
Dores musculares cervicais em pacientes com DTM e suas correlações
Líbera, J. D., Nakano, B. M. B., Guiotti, A. M., Rodrigues, J. V. S., Brandini, D. A., Devides, E. G. D. F., VOLCE, A. H. D. S., & Túrcio, K. H. L. (2022) · Revista de Odontologia da UNESP · doi:10.1590/1807-2577.04822 · Cited by 2
Halvorsen, M. M., Clench‐Aas, J., Patil, G. G., & Lundqvist, C. (2016) · Journal of Pain · doi:10.1016/j.jpain.2016.02.016 · Cited by 2
Candidate Genes and Proteomic Biomarkers of Serum and Urine in Medication-Overuse Headache
Shnayder, N. A., Sharavii, V. B., Петрова, М. М., Викторовна, М. П., Пожиленкова, Е. А., Kaskaeva, D. S., Tutynina, O. V., Popova, T. E., Garganeeva, N. P., & Nasyrova, R. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22169024 · Cited by 2
Alanazy, M. H., Almalak, H., Alaboudi, M., Abujamea, A. H., Albilali, A., & Muayqil, T. A. (2023) · Neurosciences · doi:10.17712/nsj.2023.1.20220042 · Cited by 2
Argren, M. B., Engstrand, H., Husøy, A. K., Zwart, J., & Winsvold, B. S. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01901-4 · Cited by 2
Self-citationGonzlez, C. S., del Barrio, M. T. A., & Palomo, M. J. S. (2007) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(07)74577-0 · Cited by 2
Male, old age and low income to predispose epilepsy in migraineurs
Harnod, T., Wang, Y., & Tseng, C. (2016) · European Journal of Clinical Investigation · doi:10.1111/eci.12703 · Cited by 2
Retracted: Prevalence and Burden of Headache Disorders: A Comparative Regional Study in China
Luo, N., Fang, Y., Tan, F., Zhang, Q., Zou, D., Cao, X., Xu, X., Bai, H., Ou, J., Wu, H., et al. (2010) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2010.01795.x · Cited by 2
“%) in Guangdong was lower than that of previous statistical results (51% for headache in general, 14% for migraine, 50.3% for TTH, and 4% for CDH) reported from Europe.14 Except migraine (14.3%), the prevalence of headache (41.2% for headache in general and 26.9% for TTH) in Guangxi was also lower as compared with the…”
BackgroundInfluentialRetractedBassolé, P.-R., Napon, C., Kaboré, J., & Ndiaye, M. M. (2017) · African Journal of Neurological Sciences · Cited by 2
Şen, Ç. Ç., Karlı, N., Zarifoğlu, M., Pala, K., Seferoğlu, M., & Özkaya, G. (2011) · Journal of Neurological Sciences-turkish · Cited by 2
Poply, K., Bahra, A., & Mehta, V. (2016) · BJA Education · doi:10.1093/bjaed/mkw004 · Cited by 2
Metadata
- Authors
- Stovner, L. J., Zwart, J. ‐., Hagen, K., Terwindt, G. M., & Pascual, J.
- Affiliations
- Norwegian University of Science and Technology (NO)
- Leiden University Medical Center (NL)
- Marqués de Valdecilla University Hospital (ES)
- Corresponding author
- Stovner, L. J.
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 2006-04
- Volume
- 13
- Issue
- 4
- Pages
- 333-345
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- OpenAlex
- W2054569746
- Cited by
- 421
- References
- 76
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 12 · 2023: 12 · 2022: 10 · 2021: 17 · 2020: 23 · 2019: 22 · 2018: 12 · 2017: 19 · 2016: 23 · 2015: 21 · 2014: 32 · 2013: 22 · 2012: 30
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Health Sciences › Dentistry › Oral Surgery › Temporomandibular Joint Disorders
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Keywords
- headache epidemiology, migraine, chronic headache, tension-type headache, prevalence, quality of life, absenteeism, health economics, Europe
- MeSH terms
- Adolescent, Adult, Aged, 80 and over, Child, Europe, Headache, Humans, Quality of Life, Prevalence, Cost of Illness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
